Patents by Inventor Ingegerd Adlerberth

Ingegerd Adlerberth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REDUCING THE RISK OF DEVELOPING OF ATOPIC DERMATITIS BY USE OF SUPERANTIGEN
    Publication number: 20180200358
    Abstract: A superantigen selected from the group consisting of the staphylococcal enterotoxins G and I (SEG and SEI) and staphylococcal enterotoxin-like toxins M, N and O (SEIM, SEIN and SEIO), or a mixture thereof, for use in preventing, or reducing the risk of developing, atopic dermatitis in a human being. In such use, the superantigen is mucosally administrated to a neonate within 3 months after birth.
    Type: Application
    Filed: July 13, 2016
    Publication date: July 19, 2018
    Inventors: Agnes WOLD, Ingegerd ADLERBERTH, Bill HESSELMAR, Forough NOWROUZIAN
  • Prevention of inflammatory disorders in domestic non-human mammals
    Patent number: 9375468
    Abstract: The present invention regards use of a bacterial superantigen for administration onto the mucous membrane of a domestic non-human mammal for the prevention of inflammatory disorder, such as allergies, autoimmune and inflammatory diseases.
    Type: Grant
    Filed: February 5, 2013
    Date of Patent: June 28, 2016
    Assignee: Premune AB
    Inventors: Ingegerd Adlerberth, Anna Rudin, Agnes Wold
  • Prevention of Inflammatory Disorders in Domestic Non-Human Mammals
    Publication number: 20150079131
    Abstract: The present invention regards use of a bacterial superantigen for administration onto the mucous membrane of a domestic non-human mammal for the prevention of inflammatory disorder, such as allergies, autoimmune and inflammatory diseases.
    Type: Application
    Filed: February 5, 2013
    Publication date: March 19, 2015
    Inventors: Ingegerd Adlerberth, Anna Rudin, Agnes Wold
  • Epithelial adhesive lactobacilli
    Patent number: 6159465
    Abstract: The invention refers to the use of Lactobacillus plantarum 299v having a mannose-specific adhesin for the preparation of a pharmaceutical composition inhibiting the binding of pathogenic bacteria expressing mannose-specific adhesins to the epithelial cell surface. The strain of Lactobacillus plantiarum which can be used in the invention adheres to D-mannose-coated agarose beads. The invention also refers to the use of said strain for the preparation of a pharmaceutical composition to be used in prophylatic and/or curative treatment of bacterial translocation, gastroenteritis and other diseases caused by pathogenic bacteria expressing mannose-specific adhesins.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: December 12, 2000
    Assignee: Probi AB
    Inventors: Ingegerd Adlerberth, Siv Ahrne, Bengt Jeppsson, Marie-Louise Johansson, Goran Molin, Agnes Wold